Executive Summary
MOG35-55 peptide OrderHuman MOG (1-125) Peptide Pool, a meticulously designed control pool consisting of 29 peptides for immunological research.
Peptides MOG, specifically referring to fragments of the Myelin Oligodendrocyte Glycoprotein (MOG), are crucial tools in neuroscientific research, particularly in understanding and modeling diseases affecting the central nervous system. These peptides are short chains of amino acids derived from the MOG protein, which plays a vital role in the integrity of the myelin sheath that insulates nerve fibers in the brain and spinal cord.
MOG is a transmembrane protein expressed on the surface of oligodendrocyte cells and on the outermost surface of myelin sheaths. It constitutes approximately 0.1% of the total protein in the central nervous system. Its primary function is believed to be related to the maintenance and protection of myelin. However, MOG is also implicated in autoimmune disorders where the immune system mistakenly attacks the myelin sheath, leading to demyelination.
The Significance of MOG (35-55) Peptide
Among the various peptides MOG studied, the MOG (35-55) peptide has garnered significant attention. This specific fragment, often referred to as the MOG35-55 peptide, is recognized as a potent encephalitogenic epitope. This means that when introduced into animal models, it can reliably induce an immune response that mimics human neurological diseases characterized by demyelination.
The MOG (35-55) peptide is known to induce experimental autoimmune encephalomyelitis (EAE), a widely used animal model for studying multiple sclerosis (MS) and other demyelinating diseases. The Application of MOG Protein (35-55) induces an autoantibody response that is critical for EAE development. This response involves both T cells and B cells, leading to inflammation and the destruction of myelin. Consequently, the MOG (35-55) peptide is a robust tool in MS research, allowing scientists to simulate autoimmune conditions that affect the nervous system.
Furthermore, the MOG (35-55) peptide has been described to induce a relapsing-remitting neurological disease with extensive plaque-like demyelination, which mirrors many manifestations of multiple sclerosis. This makes it an invaluable resource for investigating disease pathogenesis, testing therapeutic interventions, and understanding the mechanisms of immune-mediated demyelination. The MOG 35-55 peptide is an immunodominant epitope of MOG that induces strong T and B cell responses.
Variations and Applications of MOG Peptides
While MOG (35-55) is extensively studied, other peptides MOG fragments are also utilized in research. For instance, MOG peptide (79-96) rat is another myelin oligodendrocyte glycoprotein (MOG) fragment with known encephalitogenic effects. Researchers also utilize longer peptide pools, such as Human MOG (1-125) Peptide Pool, which consists of 29 overlapping peptides designed to cover a broader segment of the MOG protein for immunological research. Products like PepTivator® MOG are examples of such peptide collections.
The availability of MOG peptides in various species, including MOG (35-55) (human), MOG (35-55), Mouse, Rat, and even MOG peptide (human, bovine), allows for comparative studies and the investigation of species-specific immune responses. Researchers can acquire these peptides from various suppliers, with options for peptide shop online and specialized peptide research chemicals. Companies like QuantyxLabs.com offer high-quality peptides available for research purposes.
It's important to note that these peptides MOG are generally intended for research use only and are not for use in diagnostic procedures or human consumption. They serve as vital reagents for understanding complex neurological conditions and developing potential treatments.
In summary, peptides MOG, particularly the MOG (35-55) peptide, are indispensable in the field of neuroscience. Their ability to reliably induce experimental autoimmune conditions provides critical insights into the mechanisms of demyelinating diseases like multiple sclerosis, paving the way for future therapeutic advancements. The study of these MOG peptides continues to be a cornerstone in unraveling the complexities of the central nervous system and its vulnerabilities.
Related Articles
Frequently Asked Questions
Here are the most common questions about .
Leave a Comment
Share your thoughts, feedback, or additional insights on this topic.
